clinical 916 words KG: Als
Contents

Sargramostim (GM-CSF) ALS Trial

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (125)

Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.57
CYP46A1 Overexpression Gene Therapy
Score: 0.98
Transcriptional Autophagy-Lysosome Coupling
Score: 0.92
APOE-Dependent Autophagy Restoration
Score: 0.88
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.87
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.77
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Circadian Clock-Autophagy Synchronization
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Aquaporin-4 Polarization Rescue
Score: 0.73
Adenosine-Astrocyte Metabolic Reset
Score: 0.73
Phase-Separated Organelle Targeting
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
pg 1/7Next →

Related Analyses (16)

Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
How do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (30)

Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40
FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40

See Also (2)

A2M Gene
gene · KG edge: interacts_with
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates

Knowledge Graph (12 edges)

CACNA1A associated_with Als
CHAT associated_with Als
MAP2 interacts_with Als
MAP1B interacts_with Als
MAP6 interacts_with Als
MAPT regulates Als
MAP6 associated_with Als
BACE1 therapeutic_target Als
DCX interacts_with Als
CDK5 activates Als

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)